CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | AZAB MOHAMMAD Director | Grant or award | +30,456 | 104,925 | ||
| 2025-01-09 | AZAB MOHAMMAD Director | Grant or award | +15,789 | 74,469 | ||
| 2024-01-09 | AZAB MOHAMMAD Director | Grant or award | +19,480 | 58,680 | ||
| 2023-01-09 | AZAB MOHAMMAD Director | Grant or award | +20,000 | 39,200 | ||
| 2022-09-15 | AZAB MOHAMMAD Director | Grant or award | +19,200 | $6.25 | $120K | 19,200 |
Page 1 of 1 · 5 trades